Literature DB >> 18231795

Early rheumatoid arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe).

Maurizio Benucci1, Emanuela Cammelli, Mariangela Manfredi, Gianantonio Saviola, Paola Baiardi, Alessandro Mannoni.   

Abstract

The concept of Early Arthritis represents a new diagnostic-therapeutic strategy in modern rheumatology. Even if many Early Arthritis clinics are starting up, we do not yet know the frequency of this pathology in the Italian population. With the collaboration of 20 general practictioners (GPs) operating in the municipalities of Scandicci, Lastra a Signa and Signa, we assessed the incidence of rheumatoid arthritis and of new cases of Early Rheumatoid Arthritis (ERA) in the period from 1.09.2005 to 31.08.2006. The general population over 18 years old in the three municipalities according to the political electoral lists in April 2006 was as follows: Scandicci 42,474 (Males 20,290; Females 22,184), Lastra a Signa 15,368 (M 7,458; F 7,910) and Signa 13,372 (M 6,439; F 6,933). The total number of patients followed by the 20 GPs was 32,521 according to the records of ASL10 Florence. In one year 920 patients were referred by their GPs to a rheumatologist with suspected early undifferentiated arthritis according to Emery's criteria. The patients underwent a rheumatological examination and the rheumatoid factor IgM, hidden rheumatoid factors (IgG and IgA) and IgG antibodies anti-CCP (anti-cyclic citrullinate peptides) with a semiquantitative immuno-enzymatic test ELISA were investigated. In one year we observed 32 new cases of Rheumatoid Arthritis, of which 8 were males and 24 were females. The rate of incidence with respective intervals of confidence of 95% was 0.98 per thousand (0.64-1.32 per thousand). The average age was 47.7 +/- 10.5 in the females and 54.9 +/- 10.3 in the males. The patients had an average history of illness in months of 5.2 +/- 1.3 F versus 4.6 +/- 1.1 M, number of tender joints 6.2 +/- 2.3 F versus 5.3 +/- 2.2 M, number of swollen joints 4.8 +/- 1.4 F versus 4.2 +/- 1.5 M, a global assessment of 64.3 +/- 10 F versus 53 +/- 12 M, ESR (mm/h) 49.2 +/- 11.3 F versus 43.3 +/- 12.5 M, CRP (mg/dl) 2.8 +/- 1.3 F versus 2.3 +/- 1.4 M, DAS28 5.55 +/- 1.2 F versus 5.19 +/- 1.3 M, HAQ 2.5 +/- 0.4 F, 2.2 +/- 0.3 M. The rates of incidence in the Italian population affected by early rheumatoid arthritis are higher than those found in some European populations, such as those of the UK and Finland, but less than those found in the population of USA. The different data reported in the literature seem to be due to the different methods of assessing ERA and to the different types of samples studied.

Entities:  

Mesh:

Year:  2008        PMID: 18231795     DOI: 10.1007/s00296-008-0527-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  Regional differences in the incidence of rheumatoid arthritis in Finland in 1995.

Authors:  O Kaipiainen-Seppänen; K Aho; M Nikkarinen
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

2.  How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis.

Authors:  Henk Visser; Saskia le Cessie; Koen Vos; Ferdinand C Breedveld; Johanna M W Hazes
Journal:  Arthritis Rheum       Date:  2002-02

Review 3.  Early undifferentiated arthritis.

Authors:  Carol A Hitchon; Christine A Peschken; Saeed Shaikh; Hani S El-Gabalawy
Journal:  Rheum Dis Clin North Am       Date:  2005-11       Impact factor: 2.670

4.  The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985.

Authors:  S E Gabriel; C S Crowson; W M O'Fallon
Journal:  Arthritis Rheum       Date:  1999-03

5.  Estimating the incidence of rheumatoid arthritis: trying to hit a moving target?

Authors:  N Wiles; D P Symmons; B Harrison; E Barrett; J H Barrett; D G Scott; A J Silman
Journal:  Arthritis Rheum       Date:  1999-07

Review 6.  Therapeutic strategies in early rheumatoid arthritis.

Authors:  Josef S Smolen; Daniel Aletaha; Klaus P Machold
Journal:  Best Pract Res Clin Rheumatol       Date:  2005-02       Impact factor: 4.098

Review 7.  Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide.

Authors:  P Emery; F C Breedveld; M Dougados; J R Kalden; M H Schiff; J S Smolen
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

8.  Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey.

Authors:  Elina Savolainen; Oili Kaipiainen-Seppänen; Liisa Kröger; Riitta Luosujärvi
Journal:  J Rheumatol       Date:  2003-11       Impact factor: 4.666

9.  Comparison between women and men with recent onset rheumatoid arthritis of disease activity and functional ability over two years (the TIRA project).

Authors:  E Hallert; I Thyberg; U Hass; E Skargren; T Skogh
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

10.  Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study.

Authors:  F A van Gaalen; S P Linn-Rasker; W J van Venrooij; B A de Jong; F C Breedveld; C L Verweij; R E M Toes; T W J Huizinga
Journal:  Arthritis Rheum       Date:  2004-03
View more
  5 in total

1.  Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management.

Authors:  Lisa G Suter; Liana Fraenkel; R Scott Braithwaite
Journal:  Arch Intern Med       Date:  2011-04-11

2.  The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries.

Authors:  Ashok Jha; Alex Upton; William C N Dunlop; Ron Akehurst
Journal:  Adv Ther       Date:  2015-09-05       Impact factor: 3.845

3.  Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literature.

Authors:  Maurizio Benucci; Gianantonio Saviola; Mariangela Manfredi; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Int J Rheumatol       Date:  2011-11-22

Review 4.  Costs associated with rheumatoid arthritis in Italy: past, present, and future.

Authors:  Maurizio Benucci; Veronica Rogai; Fabiola Atzeni; Volker Hammen; Piercarlo Sarzti-Puttini; Alberto Migliore
Journal:  Clinicoecon Outcomes Res       Date:  2016-02-10

5.  A systematic review on time trend incidence of rheumatoid arthritis in outpatient rheumatology clinics.

Authors:  E T A M van Delft; Maha Jamal; Hannah den Braanker; T M Kuijper; J M W Hazes; Deirisa Lopes Barreto; A E A M Weel-Koenders
Journal:  Front Med (Lausanne)       Date:  2022-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.